Sign up
Quantellect · Congress · Trade Detail
HZNPHorizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST]
DemocratHouse

Daniel S. Goldman sold Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP)

Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP) since 2023, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP) on January 31, 2023. Since that trade, HZNP is up +0.00% against the S&P 500 up +87.20%, an outperformance of -87.20%.

Data updated

HZNP trades
1
Disclosed Vol
$33K
Buys
0
0%
Sells
1
100%
Buy / Sell
0.00
ratio
First → Last
2023

Daniel S. Goldman's HZNP trades vs the price

HZNP is up +0.00% since Daniel S. Goldman sold on January 31, 2023, versus +87.20% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+87.20%
Outperformance vs S&P 500
-87.20%

All Daniel S. Goldman HZNP trades

TradedTypeSizeReturnEst. profit
January 31, 2023SELL$15,001 - $50,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Daniel S. Goldman & HZNP trading FAQ

Is it legal for Daniel S. Goldman to trade Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Daniel S. Goldman sell HZNP?

Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP) on January 31, 2023, according to public STOCK Act filings.

How has HZNP performed since Daniel S. Goldman's trade?

Since Daniel S. Goldman sold HZNP on January 31, 2023, the stock is up +0.00%, versus +87.20% for the S&P 500 over the same period, an outperformance of -87.20%.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional HZNP trades?

Quantellect tracks every disclosed congressional trade in Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] (HZNP) on the Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST] congressional trading page, which aggregates filings across all members of Congress.

Daniel S. Goldman's HZNP tradesAll congressional filings for Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) [ST]Daniel S. Goldman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.